XML 34 R15.htm IDEA: XBRL DOCUMENT

Note 10. Subsequent Events	9 Months Ended
Sep. 30, 2012
Subsequent Events [Text Block]	10. Subsequent Events. From October 1, 2012 to November 7, 2012, $54,693 has been received from Stephen Chen, ABI CEO, pursuant to the arrangements described in footnote 6. This is a working capital loan to be used for operations. The working capital loan is short term, without a due date, and carries no stated interest rate or any other terms. Due to receipt of the Notice of Termination from Hayashibara Company, Inc., termination of our agreement with HBL, it became official that ABI could no longer obtain Hayashibara IFNα and; therefore, could not supply the HBL IFN to companies whose contracts (with ABI) are dependent on HBL IFN. As a result of this termination the Company will likely terminate their agreements with Bumimedic (Malaysia) Sdn. Bhd., CytoPharm, Inc., Intas Pharmaceuticals, Ltd., Cadila Healthcare.

Note 10. Subsequent Events

9 Months Ended

Sep. 30, 2012

10. Subsequent Events. From October 1, 2012 to November 7, 2012, $54,693 has been received from Stephen Chen, ABI CEO, pursuant to the arrangements described in footnote 6. This is a working capital loan to be used for operations. The working capital loan is short term, without a due date, and carries no stated interest rate or any other terms.

Due to receipt of the Notice of Termination from Hayashibara Company, Inc., termination of our agreement with HBL, it became official that ABI could no longer obtain Hayashibara IFNα and; therefore, could not supply the HBL IFN to companies whose contracts (with ABI) are dependent on HBL IFN. As a result of this termination the Company will likely terminate their agreements with Bumimedic (Malaysia) Sdn. Bhd., CytoPharm, Inc., Intas Pharmaceuticals, Ltd., Cadila Healthcare.